Hepatitis C Support Group
Hepatitis C is a blood-borne viral disease which can cause liver inflammation, fibrosis, cirrhosis and liver cancer. The hepatitis C virus (HCV) is spread by blood-to-blood contact with an infected person's blood. Many people with HCV infection have no symptoms and are unaware of the need to seek treatment. Hepatitis C infects an estimated 150-200 million people worldwide.
Galectin Theraputics is developing carbohydrate-based therapies for the treatment of fibrotic liver disease and cancer based on the Company's unique understanding of galectin proteins, key mediators of biologic function... Excellent News!!!
Thanks for posting Kramer!!! Here's more on this company and the technology behind it:
http://phx.corporate-ir.net/preview/phoenix.zhtml?c=135403&p=irol-newsArticle&ID=1792296&highlight=
Here's the technological &Scientific aspect of this:
http://www.galectintherapeutics.com/technology/fibrosis.php
Here's the poster for the previous page:
http://www.galectintherapeutics.com/objects/docs/12_EASL_2011_Poster.pdf
More info on the upcoming clinical trials to begin in May of this year:
http://www.galectintherapeutics.com/programs/liver-fibrosis.php
Here's the really technological data regarding what
galectin proteins are:
http://www.galectintherapeutics.com/technology/drug-compounds.php
And finally, this is what & how the Galectin Effect works in battling cancer:
http://www.galectintherapeutics.com/technology/cancer.php
Well, that's it for now...I'm going out now to catch some of beautiful weather... I'm Out!
Respectfully,
Henry
http://www.galectintherapeutics.com/technology/galectins.php
Ciao!
Hank
Like, really look into it.
Notice anything odd about this company?
I thought this exciting news as R&D in other HCV areasother than viral elimination.
Now are you commenting from a potential investors stance?